Abstract
Amyloidosis is the most common and devastating complication of familial Mediterranean fever (FMF). Renal transplantation is the choice of treatment of in most end-stage renal disease (ESRD). We report our experience on the outcomes in eight patients who underwent renal transplantation for ESRD due to FMF secondary to amyloidosis, and we provide a discussion on the current evidence on this topic of study. The clinical charts of eight renal transplant patients (seven male, one female) who underwent ESRD due to FMF-related amyloidosis were investigated. Five patients underwent living-donor renal transplantation and three patients underwent deceased-donor renal transplant. The mean follow-up period was 35 months (range 3–72). All patients were on triple immunosuppressive treatment and received colchicine. All allografts are currently functioning well with a mean serum creatinine level of 1.4 (range 0.7–2.6) mg/dL. Posttransplantation complications included acute rejection (n = 4), chronic rejection (n = 1), severe gastroenteritis (n = 2), and erythrocytosis (n = 5). None of the patients had proteinuria. During follow-up, we did not observe clinically severe FMF attack, septicemia, rhabdomylosis, symptoms related to vasculitis, and clinical neuropathy. The clinical outcome of the patients in this cohort was similar to that of other renal transplant patients with ESRD due to other causes. This study shows favorable prognosis of eight ESRD patients due to amyloidosis caused by FMF after renal transplantation. Renal transplantation is a safe procedure for ESRD patients having amyloidosis due to FMF. Regular use of colchicine after transplantation should be mentioned.
Similar content being viewed by others
References
Perfetto F, Moggi-Pignone A, Livi R, Tempestini A, Bergesio F, Matucci-Cerinic M (2010) Systemic amyloidosis: a challenge for the rheumatologist. Nat Rev Rheumatol 6:417–429
Röcken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440:111–122
Picken MM (2007) New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens 16:196–203
Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140:784–790
Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Med (Baltimore) 84:1–11
Akpolat T, Ozkaya O, Ozen S (2012) Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients. Gene 492:285–289
Keven K, Sengul S, Kutlay S, Ekmekci Y, Anadol E, Nergizoglu G, Ates K, Erturk S, Erbay B (2004) Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience. Transplant Proc 36:2632–2634
Altiparmak MR, Pamuk ON, Ataman R, Serdengeçti K (2004) Continuous ambulatory peritoneal dialysis in familial Mediterranean fever amyloidosis patients with end-stage renal failure: a single-centre experience from Turkey. Nephron Clin Pract 98:119–123
Ari JB, Zlotnik M, Oren A, Berlyne GM (1976) Dialysis in renal failure casued by amyloidosis of familial Mediterranean fever. A report of ten cases. Arch Intern Med 136:449–451
Saglam F, Celik A, Cavdar C, Sifil A, Atila K, Kaya GC, Bora S, Gulay H, Camsari T (2008) A renal transplant recipient with delayed gastric emptying in amyloidosis due to familial Mediterranean fever improved with erythromycin: a case report. Transplant Proc 40:308–309
Terkeltaub RA (2009) Colchicine update: 2008. Semin Arthritis Rheum 38:411–419
Emiroglu R, Başaran O, Pehlivan S, Ozdemir FN, Colak T, Moray G, Noyan T, Haberal M (2005) Effect of amyloidosis on long-term survival in kidney transplantation. Transplant Proc 37:2967–2968
Sherif AM, Refaie AF, Sobh MA, Mohamed NA, Sheashaa HA, Ghoneim MA (2003) Long-term outcome of live donor kidney transplantation for renal amyloidosis. Am J Kidney Dis 42:370–375
Jacob ET, Bar-Nathan N, Shapira Z, Gafni J (1979) Renal transplantation in the amyloidosis of familial Mediterranean fever. Experience in ten cases. Arch Intern Med 139:1135–1138
Russell PS, Winn HJ (1970) Transplantation. II. N Engl J Med 282:848–854
Turkmen A, Yildiz A, Erkoc R, Ecder T, Görçin B, Türk S, Aydin AE, Eldegez U, Ark E, Sever MS (1998) Transplantation in renal amyloidosis. Clin Transplant 12:375–378
Heering P, Hetzel R, Grabensee B, Opelz G (1998) Renal transplantation in secondary systemic amyloidosis. Clin Transplant 12:159–164
Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D, Rush D, Cole E (2005) Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ 173:1–25
Goeminne A, Missault L, Bauwens F, De Pauw M, De Sutter J (2003) Clinical experience with cardiac amyloidosis. Acta Cardiol 58:143–147
Livneh A, Zemer D, Siegal B, Laor A, Sohar E, Pras M (1992) Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever. Nephron 60:418–422
Cohen AS, Bricetti AB, Harrington JT, Mannick JA (1971) Renal transplantation in two cases of amyloidosis. Lancet 2:513–516
Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, Kastner DL (1998) Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Med (Baltimore) 77:268–297
McMullin MF (2009) Idiopathic erythrocytosis: a disappearing entity. Hematol Am Soc Hematol Educ Program 629–635
Kivity S, Danilesko I, Ben-Zvi I, Gilburd B, Kukuy OL, Rahamimov R, Livneh A (2011) Serum amyloid A levels in kidney-transplanted patients with familial Mediterranean fever-amyloidosis. Isr Med Assoc J 13:202–205
Sherif AM, Refaie AF, Sheashaa HA, El-Tantawy AE, Sobh MA (2004) Long-term evaluation of neuromyopathy in live donor FMF amyloidotic kidney transplant recipients. Am J Nephrol 24:582–586
Ozdemir BH, Ozdemir FN, Sezer S, Sar A, Haberal M (2006) Does colchicine have an antifibrotic effect on development of interstitial fibrosis in renal allografts of recipients with familial Mediterranean fever? Transplant Proc 38:473–476
Ozdemir BH, Karabay G, Ozdemir FN, Demirhan B, Haberal M (2003) Early detection of amyloidosis in renal allografts: electron microscopic, histochemical, immunohistochemical findings and relationship with graft survival. Transplant Proc 35:2639–2640
Cohen SL, Boner G, Shmueli D, Yusim A, Rosenfeld J, Shapira Z (1989) Cyclosporin: poorly tolerated in familial Mediterranean fever. Nephrol Dial Transplant 4:201–204
Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A (2002) Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers. Isr Med Assoc J 4:935–939
Celik A, Saglam F, Dolek D, Sifil A, Soylu A, Cavdar C, Temizkan A, Bora S, Gulay H, Camsari T (2006) Outcome of kidney transplantation for renal amyloidosis:a single-center experience. Transplant Proc 38:435–439
Serrano R, Martínez MA, Andrés A, Morales JM, Samartin R (1998) Familial mediterranean fever and acute myocardial infarction secondary to coronary vasculitis. Histopathology 33:163–167
Henckes M, Roskams T, Vanneste S, Van Damme B, Vanrenterghem Y (1994) Polyarteritis nodosa type vasculitis in a patient with familial Mediterranean fever treated with cyclosporin A. Transpl Int 7:292–296
Vergoulas G, Papagiannis A, Takoudas D, Papanikolaou V, Gakis D, Antoniadis A (1992) Renal transplantation and pregnancy in a patient with familial Mediterranean fever amyloidosis taking triple-drug immunosuppression and colchicine. Nephrol Dial Transplant 7:273–274
Silver J, Rosler A, Friedlander M, Popovtzer MM (1982) Unmasking of isolated hypoaldosteronism after renal allotransplantation in familial Mediterranean fever. Isr J Med Sci 18:495–498
Moser C, Pohl G, Haslinger I, Knapp S, Rowczenio D, Russel T, Lachmann HJ, Lang U, Kovarik J (2009) Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation. Nephrol Dial Transplant 24:676–678
Khosroshahi HT, Tubbs RS, Shoja MM (2006) Familial Mediterranean fever triggered by renal transplantation. Nephrol Dial Transplant 21:3000–3001
Koç M, Bihorac A, Ozener CI, Kantarci G, Akoglu E (2000) Severe hyperkalemia in two renal transplant recipients treated with standard dose of trimethoprim-sulfamethoxazole. Am J Kidney Dis 36:E18
Emeksiz H, Bakkaloglu S, Camurdan O, Boyraz M, Soylemezoglu O, Hasanoglu E, Buyan N (2010) Acute adrenal crisis mimicking familial Mediterranean fever attack in a renal transplant FMF patient with amyloid goiter. Rheumatol Int 30:1647–1649
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erdem, E., Karatas, A., Kaya, C. et al. Renal transplantation in patients with familial Mediterranean fever. Clin Rheumatol 31, 1183–1186 (2012). https://doi.org/10.1007/s10067-012-1992-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-012-1992-6